Mulugeta Russom
-
- Antibiotic Use and Resistance 6
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 8
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions 8
- Molecular Medicine top 10%
-
- Pharmaceutical Quality and Counterfeiting 5
-
- Pharmaceutical Economics and Policy 5
-
- HIV/AIDS drug development and treatment 4
- Tuberculosis Research and Epidemiology 4
-
- Schizophrenia research and treatment 4
- Co-authors
- Eyasu H. TesfamariamAraia BerhaneIsmail PashaKatia VerhammeJosé Pedro GilAsfawosen Aregay BerheBruno H. StrickerRuth Savage
- Partner nations
- EritreaNetherlandsFrance
In The Last Decade
Mulugeta Russom
41 papers receiving 475 citations
Peers
Comparison fields: 5 of 103
- Applied Microbiology and Biotechnology 193
- Geriatrics and Gerontology 129
- Toxicology 33
- Molecular Medicine 41
- Family Practice 16
Countries citing papers authored by Mulugeta Russom
This map shows the geographic impact of Mulugeta Russom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mulugeta Russom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mulugeta Russom more than expected).
Fields of papers citing papers by Mulugeta Russom
This network shows the impact of papers produced by Mulugeta Russom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mulugeta Russom. The network helps show where Mulugeta Russom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mulugeta Russom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 2 | |
| 11 | Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study | 2020 | 1 |
| 12 | 2020 | 2 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 34 | |
| 16 | Diffusion of Pharmacovigilance in the Eritrean Healthcare System: A Cross-sectional Study | 2019 | 1 |
| 17 | 2019 | 100 | |
| 18 | 2018 | 2 | |
| 19 | 2017 | 68 | |
| 20 | 2016 | 7 |
About Mulugeta Russom
Mulugeta Russom is a scholar working on Applied Microbiology and Biotechnology, Toxicology, Geriatrics and Gerontology, Infectious Diseases and Pharmacology, having authored 46 papers that have together received 495 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical Practices and Patient Outcomes (8 papers), Antibiotic Use and Resistance (6 papers), Pharmaceutical Quality and Counterfeiting (5 papers), Pharmaceutical Economics and Policy (5 papers), HIV/AIDS drug development and treatment (4 papers), Schizophrenia research and treatment (4 papers) and Tuberculosis Research and Epidemiology (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (193 citations), Geriatrics and Gerontology (129 citations), Toxicology (33 citations), Molecular Medicine (41 citations) and Family Practice (16 citations). Mulugeta Russom has collaborated with scholars based in Eritrea, Netherlands and France. Frequent co-authors include Eyasu H. Tesfamariam, Araia Berhane, Ismail Pasha, Katia Verhamme, José Pedro Gil, Asfawosen Aregay Berhe, Bruno H. Stricker, Ruth Savage, Andreas Mårtensson and Selam Mihreteab. Their work appears in journals such as Drug Safety, Pharmacology Research & Perspectives, BMJ Open, BMC Public Health and Risk Management and Healthcare Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.